eLife Submission Guide
eLife's submission process, first-decision timing, and the editorial checks that matter before peer review begins.
Readiness scan
Before you submit to eLife, pressure-test the manuscript.
Run the Free Readiness Scan to catch the issues most likely to stop the paper before peer review.
This guide is one part of a 3-source submission path.
The Journal Submission Source Map separates the official pages that resolve Scope & fit, Article type & genre, Package requirements, and Review model & anonymity for eLife.
Journal overview
- Aims and scope
- Resolves: Scope & fit, Article type & genre
- Required for the mapped core job
Author workflow
- Submit your research
- Resolves: Package requirements
- Required for the mapped core job
How to approach eLife
Use the submission guide like a working checklist. The goal is to make fit, package completeness, and cover-letter framing obvious before you open the portal.
Stage | What to check |
|---|---|
1. Scope | Post your preprint on bioRxiv |
2. Package | Submit to eLife via the submission portal |
3. Cover letter | Senior Editor assessment |
4. Final check | Peer review with reviewer consultation |
Quick answer: A strong eLife submission guide starts with model fit. eLife operates the publish-review-curate model: submissions go through Elifesciences author instructions and every manuscript editors select for review is published as a Reviewed Preprint (preprint + eLife Assessment + Public Reviews + author response).
The $3,750 APC is charged when eLife commits to reviewing, and there is no traditional accept/reject decision after review. If the team needs private review, confidentiality, or a binary accept/reject path, eLife is the wrong target.
Run an Elife pre-submission readiness check before clicking submit, or work through this guide manually.
From our manuscript review practice
Of manuscripts we've reviewed for eLife, papers where the authors are not ready for the open peer review model because the evidence is too fragile to withstand public scientific scrutiny is the most consistent desk-rejection trigger. eLife's strength lies in transparent review; if your findings cannot survive that transparency, the platform is the wrong choice.
eLife at a glance
Metric | Value |
|---|---|
Impact Factor (2024 JCR) | 6.4 |
Publisher | eLife Sciences (independent, non-profit) |
Submission portal | Elifesciences author instructions (main) and Submit author instructions (legacy Feature Articles + Scientific Correspondence) |
Editorial model | Publish-Review-Curate (every reviewed manuscript publishes as a Reviewed Preprint) |
APC | $3,750 USD (charged at point of commitment to review; waivers available) |
Preprint requirement | Authors may submit directly or transfer from bioRxiv / medRxiv; a preprint is required if the paper is sent for review (eLife can post one) |
Article types | Research Article, Short Report, Tools and Resources, Research Advance, Replication Study, Review Article, Feature Article, Scientific Correspondence |
Word / figure limits | No maximum length for Research Articles (eLife suggests keeping the main text under 5,000 words, excluding Materials and methods, References and figure legends) and no limit on display items; Short Reports should not usually exceed 1,500 words and three or four main display items |
Abstract length | Normally 150 to 200 words (subheadings discouraged except for medical submissions) |
eLife Assessment | Two-axis: significance (Landmark / Fundamental / Important / Valuable / Useful) + strength of evidence (Exceptional / Compelling / Convincing / Solid / Incomplete / Inadequate) |
Public review | Yes; reviewer + editor public reviews published with the Reviewed Preprint |
ISSN | 2050-084X (online) |
DOI prefix | 10.7554/eLife.* |
Source: eLife author guide, eLife submit page, accessed October 2026.
Editorial triage: stage-by-stage timeline
ELife editorial workflow at Elifesciences author instructions runs on the Publish-Review-Curate model. Editors weigh whether the work is of substantial interest, whether they can find high-quality reviewers, and whether the reviews will be valuable to the scientific community.
Receipt and checks
eLife staff perform quality and integrity checks on submissions, and authors supply the author declarations, the data availability statement and, if the work is already posted, the preprint identifier (bioRxiv / medRxiv / other preprint server). eLife does not publish a timetable for this step.
Editor evaluation (no-cost screen)
eLife reports a median of 8 days to a decision when an article is not selected for review (2025). A Senior Editor, usually after asking a small number of Reviewing Editors, decides whether the manuscript warrants peer review. If the editors commit to peer review, the $3,750 APC is charged at this point. If they decline review, no APC is charged and the preprint remains on bioRxiv / medRxiv if it was posted there.
External peer review
Reviewers each write a Public Review and recommendations for the authors. Reviewer identities are not revealed in the Public Reviews, which are signed by eLife rather than by individuals. Reviewers and the editor then consult to produce a consolidated eLife Assessment.
Reviewed Preprint publication
ELife posts the Reviewed Preprint two weeks after the reviews are sent to authors (median 96 days from submission in 2025). This includes the paper, the eLife Assessment (significance + strength of evidence), Public Reviews, and the author response if provided. There is no traditional accept/reject decision; every reviewed paper publishes as a Reviewed Preprint.
Author iteration + Version of Record
Authors choose whether to revise + respond. Authors can request a Version of Record at any point after review, without changes if they wish, although most go through a round of revisions first; eLife asks for the request within 12 months of the latest Reviewed Preprint. The Version of Record is identical to the most recent Reviewed Preprint apart from minor changes that do not affect the scientific content.
eLife vs peer life-sciences journals
This peer-comparison table compares eLife with the journals authors typically choose between when the biological-research story sits near a boundary. Numbers are JCR 2024 IFs, published acceptance ranges, and typical evidence thresholds. Nature, Cell, Science, and PNAS publish adjacent highest-impact life-sciences work for context.
Journal | JIF (2024) | Acceptance rate | Decision turnaround | OA model | Editorial focus |
|---|---|---|---|---|---|
eLife | 6.4 | About 27% to 35% (selected for review, eLife 2023 to 2025) | Median 96 days to Reviewed Preprint (2025) | Gold OA ($3,750) | Publish-Review-Curate life sciences |
PLOS Biology | 6.9 | ~14% | 12-16 weeks | Gold OA ($5,300) | Broad biology, high editorial bar |
Cell Reports | 7.7 | Not verified | 8-12 weeks | hybrid (Cell Press) | Broad biology, fast |
Nature Communications | 18.1 | ~8% | 14-22 weeks | Gold OA ($7,350) | Cross-disciplinary highest-impact (Springer Nature) |
EMBO Journal | 8.4 | ~18% | 10-14 weeks | hybrid | Molecular biology + cell biology |
Science Advances | 13.9 | ~10% | 10-14 weeks | Gold OA ($5,450) | Cross-disciplinary high-impact (AAAS / Science) |
Publisher-reported acceptance figures link to their source. Elsevier catalog figures were checked on October 21, 2026; the catalog does not specify the reporting period or submission denominator. “Not verified” means we have not confirmed a current figure.
Source: eLife / PLOS / Cell Press / Nature Portfolio / EMBO Press / AAAS journal pages, JCR 2024, accessed May 2026.
eLife submission package: required artifacts
Editors and staff check eLife uploads against the following items (Elifesciences author instructions).
The items are the manuscript text file (DOCX, DOC, RTF or LaTeX, with figures uploaded as separate files), the preprint details if the work is already posted (bioRxiv and medRxiv transfers are supported directly), an abstract (normally 150 to 200 words), the author contributions statement (eLife asks authors to use the CRediT taxonomy), the competing interests declaration for each author, the funding information with grant numbers where possible, the Data Availability Statement (required for all eLife papers), the program code and other documentation needed to reproduce the results, the ethics statement for human or animal work, and any supplementary files. A cover letter is required for Review Articles and expected for Replication Studies, and it is where data-availability exceptions are requested.
What official pages do not answer
Most official and generic pages for "eLife submission guide" summarize the reviewed-preprint workflow or list author instructions. That is necessary, but it does not answer the author-risk question: whether a specific manuscript should enter a model where peer reviews and the editor assessment become public artifacts.
This guide translates eLife's model into editorial screen logic. Official publisher guidance cannot tell you whether the manuscript's missing controls would become damaging public review language, whether the data and code package is ready to be inspected, or whether the author team is aligned on publishing a visible eLife Assessment.
What this page is for
This page is about package readiness, not post-submission workflow.
Use it when you are still deciding:
- whether the manuscript is ready to be a preprint and a reviewed preprint
- whether the evidence is strong enough for a public assessment
- whether the data, code, and methods are open-science ready
- whether the authors are genuinely comfortable with the model
If you want the post-upload workflow and timing, that belongs on the submission-process page.
Start with model readiness
Many weak eLife submissions are not weak because of the science alone. They are weak because the team has not fully accepted what submitting to eLife means in practice.
The manuscript needs to be public as a preprint or ready to become one during submission. If the team still needs confidentiality, competitive delay, or private circulation before making the paper publicly accessible, that is already a fit problem regardless of how strong the science is. Preprint readiness is not optional at eLife; it is part of the submission standard.
The authors should also be able to tolerate public reviews, public criticism, and an eLife Assessment that may be less flattering than a private decision letter. If that feels unacceptable, the right answer is often another journal rather than hoping for a more favorable public outcome. Teams that submit to eLife expecting a conventional private review process are consistently surprised by how much the model differs from that expectation.
What should already be in the package
Before the formal submission starts, the package should already contain:
- a manuscript ready to exist publicly as a preprint
- evidence strong enough to survive a public "strength of evidence" assessment
- data, code, and methods that are genuinely transparent enough to inspect
- an author team aligned on the reviewed-preprint model
- a cover letter that explains why eLife is the right publication model
When those pieces are still unstable, the problem is not the portal. It is that the package is not ready for eLife yet.
eLife Submission Checklist Before Upload
- [ ] The manuscript is ready to exist publicly as a preprint without additional private circulation.
- [ ] The key figures can withstand public reviewer criticism without obvious missing controls.
- [ ] Data, code, methods, and availability statements are complete enough for outside inspection.
- [ ] The author team has agreed that public reviews and an eLife Assessment are acceptable outcomes.
- [ ] The cover letter explains why transparent assessment is right for this paper, not just why the paper is important.
- [ ] The revision plan can tolerate public critique being attached to the work before a Version of Record.
Readiness check
Run the scan while eLife's requirements are in front of you.
See how this manuscript scores against eLife's requirements before you submit.
What eLife editors are really screening for
ELife editors are not only asking whether the paper is good. They are asking:
- does the manuscript make a real contribution in the life sciences?
- is the evidence strong enough to justify public review?
- will the reviewed-preprint model help rather than hurt this paper?
- does the submission fit the journal's open-science posture?
That is why a technically strong paper can still be a weak eLife submission if the authors are not ready for the model itself.
When eLife is the wrong choice
Warning sign | Why it matters |
|---|---|
The team wants a traditional private review and a clean binary decision | eLife's reviewed-preprint model does not provide a private gate or a simple accept/reject outcome; if the authors need conventional review confidentiality, the model mismatch is a submission problem before any science is judged |
The evidence looks too vulnerable for public scrutiny | At eLife, reviewer criticism becomes part of the permanent visible record; a paper with obvious methodological fragility, missing controls, or statistical instability may fare worse in this model than at a private-review journal where those concerns stay in a confidential decision letter |
The open-science package is incomplete | Missing code, provisional data availability statements, or methods that rely on informal lab knowledge undermine the journal's core posture; eLife editors screen for open-science readiness before routing for public review |
The cover letter argues prestige rather than model fit | The strongest eLife cover letters explain why transparent assessment is right for this specific paper; letters that frame eLife as a high-status badge without explaining model alignment consistently signal mismatch before the science is read |
What the cover letter should do
The cover letter should do three things:
- state the scientific contribution plainly
- explain why eLife is the right audience and review model
- signal that the team understands the reviewed-preprint path
It should not sound like a conventional prestige pitch. That usually signals model mismatch.
A practical pre-submit matrix
If this is true | Best move |
|---|---|
The paper is strong and the team values transparent review | Submit |
The science is good but the team is uneasy about public assessment | Reconsider the journal choice |
The manuscript still needs confidentiality or a private review phase | Do not submit to eLife |
The evidence is still too fragile for public scrutiny | Strengthen first |
What a review-ready eLife package actually proves
The easiest mistake here is to treat eLife like a conventional journal with a slightly unusual workflow. That misses the real decision. A conventional submission can still succeed when the manuscript is promising but the authors expect the private review process to help stabilize the package. eLife works better when the package is already stable enough to stand in public.
That usually means an editor can see four things quickly.
The manuscript can survive public reading immediately
The preprint version should already look like something the team is comfortable having colleagues, competitors, and future reviewers read as a finished public object. If the team still thinks of the paper as "almost ready" or is counting on the review process to help stabilize the package, eLife is usually the wrong choice at this stage. Papers that depend on private review to define what the missing experiments should be are better served by journals where that negotiation happens confidentially rather than in a public assessment attached to a preprint.
The evidence chain is sturdy enough for an assessment, not just a decision
At eLife, the public record is not only whether the paper moved forward. It is also how the editors and reviewers describe the strength of evidence. That means vulnerability matters differently here. A paper with obvious missing controls, unstable statistics, or a methods section that still depends on informal lab knowledge can end up carrying that weakness visibly.
The open-science materials are part of the editorial case
This is not just a box-checking issue. If the code, data, methods, and availability statements are weak or incomplete, the submission feels culturally mismatched with the journal even before anyone reads the science. eLife's core posture treats data and code availability as a baseline expectation, not an optional supplement. Editors assess whether the transparency posture is genuine before routing a submission for public review, and packages where open-science materials are clearly retrofitted or provisional are identified as premature regardless of the scientific quality of the findings themselves.
The author team is aligned on what a public record means
The corresponding author may be ready for transparent review while coauthors are not. That mismatch becomes a real submission problem later. Before submitting, make sure the whole team understands that the reviews, assessment, and preprint presence are part of the product rather than a temporary step on the way to a hidden decision.
How to choose between eLife and a conventional journal
Many borderline eLife submissions are really unresolved journal-choice decisions. The manuscript may be strong enough to publish, but the team is still choosing between transparent assessment and a more traditional private process.
If the real priority is... | eLife is stronger when... | A conventional journal is stronger when... |
|---|---|---|
Public scientific evaluation | the team wants the reviewed-preprint model and can tolerate visible criticism | the team wants the review conversation to stay private |
Open materials and reproducibility | the data, code, and methods are already ready for inspection | key materials still need cleanup before broad public scrutiny |
Narrative control | the authors are comfortable with an assessment that may be nuanced rather than celebratory | the authors want a simpler accept/reject signal first |
Speed to a public record | the group wants the paper visible and discussable quickly | the group is still managing confidentiality or competitive timing |
This comparison matters because the wrong choice here creates a bad experience even when the science is good. The problem is not that eLife "rejected" the paper. The problem is that the authors asked the wrong publication model to solve the wrong problem.
The strongest eLife submissions read differently on page one
The first page of a strong eLife submission usually feels calmer and more disciplined than authors expect. It does not rely on prestige language or dramatic framing. Instead, it makes the paper look ready for a public expert conversation.
That usually means:
- the abstract states the real contribution without overselling certainty
- the limitations are not hidden or apologized away
- the methods and availability posture look deliberate, not retrofitted
- the central claim is strong enough to survive visible criticism
If page one still depends on rhetorical momentum, the manuscript is often better suited to another route first.
Bottom line
The best eLife submissions are prepared at the level of publication model, not only scientific content. The science is strong, the open-science materials are ready, the authors are comfortable with public review, and the team sees reviewed-preprint publication as a feature rather than a concession.
That is the real submission standard.
What to read next
Before you submit, run your manuscript through a eLife submission readiness check to catch issues that will look worse once reviews are public.
What Makes eLife Different From Every Other Journal
ELife operates a fundamentally different editorial model:
Feature | eLife | Traditional journals |
|---|---|---|
APC | $3,750 (for submissions from July 1, 2026; waivers available) | $2,477-$11,390 |
Review model | Reviewed preprints (post on bioRxiv first) | Confidential peer review |
Review reports | Published alongside the paper | Confidential |
eLife assessment | Public editorial summary of strength and significance | None |
Rejection after review | None (every reviewed paper is published as a Reviewed Preprint) | Common |
Revision rounds | Optional; over 96% of VORs follow at least one revision (eLife) | Often 2-3 |
The key difference: eLife doesn't reject papers after review. Instead, it publishes them with a public "eLife assessment" that rates the strength of evidence and significance of claims. This means getting into review is the hard part. Once reviewed, your paper gets published regardless of the outcome.
When eLife Is the Right Strategic Choice
Choose eLife if:
- You want transparent, published peer review alongside your paper
- You're comfortable with public reviewer reports and an eLife Assessment rating
- Your paper is already on a preprint server (bioRxiv, medRxiv) or you're willing to post one
- You value the "publish then review" model, once accepted for review, the paper publishes regardless of outcome
- Speed matters: median time from submission to published Reviewed Preprint was 96 days in 2025
Choose elsewhere if:
- You need a traditional JIF signal for career purposes (Web of Science put eLife on hold in October 2024, and eLife is not eligible for a Clarivate impact factor)
- You're not comfortable with public reviewer reports attached to your paper
- The $3,750 APC is a barrier (though waivers are available for those who can't pay)
- Your institution or promotion committee doesn't recognize eLife's reviewed preprint model
A eLife submission readiness check can help you decide whether eLife's reviewed preprint model is right for your paper or whether a traditional journal submission serves your goals better.
The references cover process; they say nothing about whether this draft is ready. The review tells you whether your paper clears the eLife fit check before upload, especially around authors not ready for public reviews and visible eLife Assessment, evidence too fragile for public expert scrutiny at submission, and open-science materials incomplete at time of submission. Paid Manusights reviews include a 60-day money-back guarantee, and we do not train models on submitted manuscripts.
Decision risks before submitting to Elife
For manuscripts targeting eLife, five patterns generate the most consistent submission problems worth knowing before committing to the reviewed-preprint model.
Authors not ready for public reviews and visible eLife Assessment
The eLife submission information positions eLife as a reviewed-preprint journal where reviews and the editorial assessment are published alongside the paper and are permanently part of the record.
In our pre-submission review work, we see many teams discover after submission that public reviewer criticism and a visible strength-of-evidence assessment are harder to accept than they anticipated, particularly when the eLife Assessment characterizes the findings as "useful" or "solid" rather than "landmark." Editors specifically screen for teams that have genuinely accepted the model rather than treating it as a conventional private review with unusual branding.
Evidence too fragile for public expert scrutiny at submission
We also often find many submissions contain methodological vulnerabilities, missing controls, or statistical fragility that would be manageable under private review but become part of the permanent public record when reviewers document them in eLife's public review model. In practice, editors consistently redirect manuscripts where obvious evidentiary gaps would generate public reviewer comments that would attach to the paper indefinitely, because eLife's model means reviewer criticism is a persistent feature of the published record rather than a private negotiation.
Open-science materials incomplete at time of submission
A related pattern is that many submissions arrive with code not yet deposited, data availability statements that are still provisional, or methods sections that rely on informal lab knowledge rather than reproducible documentation. Editors consistently screen for open-science readiness because the journal's core posture treats data and code availability as part of the submission standard, and our analysis of submission difficulties at eLife shows that retrofitting open-science materials after review is treated as an indicator that the submission was premature.
Check open science materials incomplete at time of submission before submitting to eLife →
Team submitting for prestige signal rather than model alignment
A related pattern is that many submissions treat eLife as a high-status traditional journal and frame the cover letter around impact and significance claims rather than explaining why transparent public assessment and the reviewed-preprint model are the right publication route for this specific paper. In our analysis of submission difficulties at eLife, this pattern is most common in groups where the corresponding author has accepted the model but coauthors still expect a conventional binary decision and are not prepared for the public record.
Check team submitting for prestige signal rather than model alignment before submitting to eLife →
Cover letter argues prestige rather than reviewed-preprint fit
A related pattern is that many submissions arrive with cover letters that describe the paper's importance and impact without explaining why eLife's specific model of transparent assessment and preprint publication serves the paper better than a conventional journal would. Editors explicitly consider whether the cover letter demonstrates genuine model alignment before routing the paper for public assessment.
SciRev author-reported review times and Clarivate JCR 2024 bibliometric data provide additional benchmarks when planning your submission timeline.
Before submitting to eLife, a eLife submission readiness check identifies whether your evidence package, open-science materials, and team alignment meet the standards for the reviewed-preprint model before you commit to the submission.
Check cover letter argues prestige rather than reviewed preprint fit before submitting to eLife →
Submit If
- the manuscript is ready to exist publicly as a preprint, evidence is strong enough for public expert scrutiny, and the author team accepts the reviewed-preprint model
- data, code, and methods are genuinely transparent and already organized for inspection, with open-science materials complete at submission
- the entire team is aligned that public reviews, public criticism, and a visible eLife Assessment are acceptable outcomes
- the scientific contribution justifies transparent, published peer review rather than requiring private negotiation around vulnerable findings
Think Twice If
- the title and abstract still need private reviewer feedback before the team is comfortable posting the work as a public preprint
- Figure 1 or the core statistics have missing controls, underpowered comparisons, or fragile exclusions that reviewers would likely describe publicly
- the data availability statement is provisional, code is not deposited, or methods depend on informal lab knowledge that an outside reader cannot inspect
- the cover letter argues eLife prestige rather than explaining why transparent assessment and the reviewed-preprint model are right for this manuscript
Evidence Basis
Across our eLife pre-submission reviews, the thing authors most need to understand is the journal's model: eLife now reviews and publishes with public Reviewed Preprints and assessments rather than a binary accept or reject, so the editorial question at submission is whether the work is important and rigorous enough to merit that public review, decided by editors who are active scientists. The work that gets sent for review makes a clear case for significance and methodological soundness in its field. Submit if your study is rigorous and advances an important question your community will engage with; think twice if the contribution is preliminary or narrow, since the editorial screen still gates what enters the process.
This guide was checked against eLife's current submission page, peer-review model page, author instructions, recent eLife explanation of Reviewed Preprints, and our pre-submission review work on life-sciences submissions considering public review.
ELife says papers selected for peer review are published as Reviewed Preprints with the preprint, an eLife Assessment, Public Reviews, and optional author response. That changes the pre-submit decision from formatting readiness to public-record readiness. Source limitations: we did not test a private live eLife submission session for this page; portal guidance is based on public eLife materials and pre-submission review patterns.
If you want the quick pre-upload call, run a eLife manuscript fit check before submitting to eLife's reviewed-preprint workflow.
- eLife journal overview, Manusights internal guide.
- eLife submission information, eLife.
Frequently asked questions
Upload through the eLife submission portal at the official author instructions eLife operates a Publish-Review-Curate model: submit a preprint (or post one during submission via bioRxiv / medRxiv), editors decide whether to send for review, and every reviewed paper publishes as a Reviewed Preprint with an eLife Assessment, Public Reviews, and author response. The $3,750 APC is charged when eLife commits to peer review.
eLife reports a median of 8 days to a decision when an article is not selected for review (no fee is charged if declined), and a median of 96 days from submission to a published Reviewed Preprint (2025). The Reviewed Preprint is posted about two weeks after the reviews are sent to authors. There is no traditional accept/reject decision after review. A Version of Record can be requested at any point after review. The $3,750 fee is waived for authors who cannot pay.
There is no submission fee. The eLife publishing APC is $3,750 USD (for submissions from July 1, 2026), charged only when eLife commits to peer review. Fee waivers are available for authors who cannot pay. Institutional publishing agreements may cover the fee; verify your institution's eLife coverage before submission.
The two most common patterns are (1) significance below eLife's threshold (the editor evaluation pre-review screens out manuscripts that would not meaningfully advance the field), and (2) team-readiness mismatch, where authors need confidentiality or a binary accept/reject path do not fit the Publish-Review-Curate model. Methodologically weak papers are also screened out at this stage, before the $3,750 APC is charged.
Traditional peer review ends in accept or reject; eLife ends in publication of a Reviewed Preprint with a two-axis Assessment (significance: Landmark / Fundamental / Important / Valuable / Useful; strength of evidence: Exceptional / Compelling / Convincing / Solid / Incomplete / Inadequate) plus Public Reviews. Reviewer identities are not revealed: Public Reviews are signed by eLife rather than by individual reviewers. The model rewards transparent science but is wrong for authors needing confidentiality.
Final step
Submitting to eLife?
Run the Free Readiness Scan to see score, top issues, and journal-fit signals before you submit.
Target journal eLife
Private API processing. Your manuscript is not used to train models.
See example reportsPut the guidance to work
Turn the guide into a complete submission package.
Use one final checklist, then verify the journal rule that controls the files, declarations, and reporting details you will submit.
Where to go next
Start here
Same journal, next question
- How to Avoid Desk Rejection at eLife in 2026
- eLife Submission Process: The Reviewed Preprint Model Explained
- eLife Pre-Submission Checklist: Is Your Paper Ready for the Reviewed Preprint Model?
- eLife Review Time: What to Expect Under the New Model
- eLife 'Under Review': What Each Status Means and When to Expect a Decision
- Is eLife a Good Journal? The Publish-Then-Review Experiment Explained